KARYOPHARM THERAPEUTICS INC.

Profile

Company Names

KARYOPHARM THERAPEUTICS INC.

Addresses

85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA 02459

2 MERCER ROAD, NATICK, MA 01760

15 BONTEMPO ROAD, NEWTON, MA 02459

Phone Numbers

617-658-0600
508-975-4820
617-921-4822

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$205,199,999.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-12-07 
$165,000,003.00 
$165,000,003.00 
$0.00 
Equity 
3
2013-07-26 
$18,999,996.00 
$18,999,996.00 
$0.00 
Equity 
2
2013-04-17 
$20,500,000.00 
$60,000,000.00 
$39,500,000.00 
Equity 
1
2010-10-21 
$700,000.00 
$20,750,000.00 
$20,050,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALAN 
 
BARBER 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC   |  KARYOPHARM THERAPEUTICS INC.   |  ARCH THERAPEUTICS, INC.
GAREN 
G. 
BOHLIN 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.
PAUL 
 
BRANNELLY 
EXECUTIVE OFFICER
VERASTEM, INC.   |  KARYOPHARM THERAPEUTICS INC.   |  COLLEGIUM PHARMACEUTICAL, INC   |  RIBON THERAPEUTICS, INC.
SOHANYA 
 
CHENG 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.
RONALD 
 
DEPINHO 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  KARYOPHARM THERAPEUTICS INC.   |  TVARDI THERAPEUTICS, INC.
BARRY 
 
GREENE 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.   |  VICARIOUS SURGICAL INC.   |  SAGE THERAPEUTICS, INC.   |  TRU PRECIOUS METALS CORP.   |  DEEP SEA MINERALS CORP.
BARRY 
E. 
GREENE 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  KARYOPHARM THERAPEUTICS INC.
PETER 
 
HONIG 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.
MICHAEL 
 
KAUFFMAN 
DIRECTOR, EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.   |  METAMARK GENETICS, INC.   |  VERASTEM, INC.   |  KEZAR LIFE SCIENCES, INC.
MICHAEL 
 
MANO 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.
MICHAEL 
 
MASON 
EXECUTIVE OFFICER
WALTHAM ADMINISTRATIVE MANAGEMENT, L.L.C.   |  BOSTON OUT-PATIENT SURGICAL SUITES, L.L.C.   |  ECU SILVER MINING INC   |  KARYOPHARM THERAPEUTICS INC.
MANSOOR 
RAZA 
MIRZA 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.   |  METAMARK GENETICS, INC.   |  SERA PROGNOSTICS, INC.
STEPHEN 
 
MITCHENER 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.
CHRISTY 
J. 
OLIGER 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.
DEEPIKA 
 
PAKIANATHAN 
DIRECTOR
PHENOMIX CORP   |  KARYOPHARM THERAPEUTICS INC.   |  CALITHERA BIOSCIENCES, INC.   |  ALDER BIOPHARMACEUTICALS INC
DEEPIKA 
R. 
PAKIANATHAN 
DIRECTOR
KARYOPHARM THERAPEUTICS INC.
RICHARD 
 
PAULSON 
EXECUTIVE OFFICER, DIRECTOR
KARYOPHARM THERAPEUTICS INC.
STUART 
 
POULTON 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.
RESHMA 
 
RANGWALA 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.
CHEN 
 
SCHOR 
DIRECTOR
CERAPEDICS INC   |  BRAINSTORM CELL THERAPEUTICS INC.   |  NOVALERE FP, INC.   |  CARBON BIOSCIENCES, INC.   |  KARYOPHARM THERAPEUTICS INC.
SHARON 
 
SHACHAM 
EXECUTIVE OFFICER
KARYOPHARM THERAPEUTICS INC.   |  ACRIVON THERAPEUTICS, INC.   |  REGENIMO BIOSCIENCES, INC.   |  NASUS PHARMA LTD
KENNETH 
E. 
WEG 
DIRECTOR
METAMARK GENETICS, INC.   |  KARYOPHARM THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-07 
2013-08-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-26 
2013-05-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-17 
2010-11-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
2347
PIPER SANDLER + CO.
NONE
PIPER SANDLER + CO.
665
NONE
NONE
BARCLAYS CAPITAL, INC.
19714
NONE
NONE
ROBERT W. BAIRD + CO. INCORPORATED
8158
NONE
NONE
H.C. WAINWRIGHT + CO. LLC
375